KR830007550A - 시클릭아민의 제조방법 - Google Patents

시클릭아민의 제조방법 Download PDF

Info

Publication number
KR830007550A
KR830007550A KR1019810004985A KR810004985A KR830007550A KR 830007550 A KR830007550 A KR 830007550A KR 1019810004985 A KR1019810004985 A KR 1019810004985A KR 810004985 A KR810004985 A KR 810004985A KR 830007550 A KR830007550 A KR 830007550A
Authority
KR
South Korea
Prior art keywords
compound
hydroxy
alkyl
aryl
alkoxy
Prior art date
Application number
KR1019810004985A
Other languages
English (en)
Inventor
태영서 존
훈 정 락
내-이왕
네일 바르톤 제퍼레이
Original Assignee
모리스이. 실버스테인
유에스브이 파마슈티칼 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모리스이. 실버스테인, 유에스브이 파마슈티칼 코포레이션 filed Critical 모리스이. 실버스테인
Publication of KR830007550A publication Critical patent/KR830007550A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/32Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups bound to acyclic carbon atoms and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

내용 없음

Description

시클릭아민의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 상용하는 데하이드로 피롤리딘 화합물의 에틸렌성 이중결합을 환원시키고, R이 수소인 화합물에서는 수소를 수소가 R이 아닌 다른 기타의 치환체로 임의로 치환시킴을 특징으로 하여 하기 일반식(Ⅰ) 및 (Ⅱ)를 제조하는 방법.
    상기식에서
    Z와 Y는 각각 주요체인에 탄소원자 1내지 5를 함유한 알킬렌이거나 OH, 알카노일옥시, 알콕시, 멜캅토 또는 알킵멜캅토로 치환된 전기의 알킬렌이며,
    R1,R2및 R3각각은 독립적으로 H, 알킬, 아릴, 할로, 알콕시, 알케닐옥시, 알킬설피닐, 알킬설포닐, 알킬멜캅토, 시아노, 카복시, 카브알콕시, 카복스아미도, 설파모일, 트리플루오로메틸, 히드록시, 히드록시알킬, 아실옥시, 알킬아미노, 설포닐아미노, 또는 아실아미노이며, R1과 R2함께 취하여 메틸렌 디옥시 또는 -O-CO-O-를 형성하며,
    Ar은 헤테로아릴, 시클로 알킬 또는 하기의 일반식이며,
    (상기식에서 R1,R2,R3는 전술한 바와 같다)
    R은 H, 알킬 시클로알킬, 아릴, 아르알킬 (aralkyl), 알케닐, 알키닐, 카보알콕시, 또는 CONR4R5이며, R4와 R5각각은 H 또는 알킬이며, 각 하이드로카빌기에서 탄소원자의 총수는 10까지이다.
  2. 제1항에 있어서, 환원을 촉매 수소화 반응에 의해 실행하는 방법.
  3. 제2항에 있어서, 수소화 반응을 귀금속 촉매상에서 실시하는 방법.
  4. 제3항에 있어서, 촉매가 팔라듐 또는 백금 수소화 반응촉매인 방법.
  5. 제1항 내지 제4항중의 어느하나에 있어서, 환원 생성물이 하기 일반식(Ⅲ)과 (Ⅳ)의 화합물인 방법.
    상기식에서
    R1및 R2각각은 독립적으로 H, 알킬, 아릴, 할로 알콕시, 알케닐옥시, 알킬설피닐, 알킬설포닐, 알킬멜캅토, 시아노, 카복시, 카브알콕시, 카복스아미도, 설파모일, 트리플루오로메틸, 히드록시, 히드록시알킬, 아실옥시, 알킬아미노, 설포닐아미노 또는 아실아미노이며, R1과 R2함께 취하여 메틸렌디옥시 또는 -0-CO-O-를 형성하며
    R6는 H, 알킬, 아릴, 할로, 알콕시, 알케닐옥시, 알킬설포닐, 알킬멜캅토, 시아노, 카복시, 카브알콕시, 카복스아미도, 설파모일, 트리플루오로메틸, 히드록시, 히드록시알킬, 아실옥시, 알킬아미노, 설포닐아미노 또는 아실아미노이며,
    각 하이드로 카빌기에서 탄소원자의 총수는 10까지이다.
  6. 제1항내지 제4항중의 어느 하나에 있어서, 환원 생성물이 하기 일반식의 화합물인 방법.
    상기식에서 R1,R2및 R6는 독립적으로 히드록시 또는 알카노일옥시이고, 알카노일옥시의 알킬부분은 탄소원자 6까지 함유한다.
  7. 제1항내지 제4항중의 어느하나에 있어서, 환원 생성물이 하기 일반식의 화합물이 방법.
    상기식에서 R1,R2,R3,Z,Y 및 Ar은 전술한바와 같다.
  8. 제1항내지 항4중의 어느 하나에 있어서, 환원 생성물이 하기 일반식의 화합물인 방법.
    상기식에서 R1과 R2각각은 독립적으로 H, 알킬, 아릴, 할로, 알콕시, 알케닐옥시, 알킬설피닐, 알킬설포닐, 알킬멜캅토, 시아노, 카복시, 카브알콕시, 카복스아미도, 설파모일, 트리플루오로메틸, 히드록시, 히드록시알킬, 아실옥시, 알킬아미노, 설포닐아미노 또는 아실아미노이며, R1과 R2함께 취하여 메틸렌디옥시 또는 -O-CO-O-를 형성하며
    R6는 H, 알킬, 아릴, 할로, 알콕시, 알케닐옥시, 알킬설포닐, 알킬멜캅토, 시아노, 카복시,카브알콕시, 카복스아미도, 설파모일, 트리플루오로메틸, 히드록시, 히드록시알킬, 아실옥시, 알킬아미노, 설포닐아미노 또는 아실아미노이며,
    각 하이드로카빌기에서 탄소원자의 총수는 10까지이고, 지방족기는 탄소원자수 7까지이며 방향족기는 탄소수 10까지 함유한다.
  9. 제1항내지 제4항중의 어느 하나에 있어서, 환원생성물이 하기 구조식의 화합물인 방법.
  10. 제1항내지 제4항중의 어느 하나에 있어서, 환원생성물이 하기 구조식의 화합물인 방법.
  11. 제1항내지 제4항중의 어느 하나에 있어서, 환원생성물이 R1,R2, 및 R3가 각각 히드록시인 제6항에 따르는 화합물인 방법.
  12. 제1항내지 제4항중의 어느 하나에 있어서, 환원생성물이 R1,R2및 R3가 각각 알카노일옥시인 제6항에 따르는 화합물인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810004985A 1980-10-20 1981-12-18 시클릭아민의 제조방법 KR830007550A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/198,671 US4342692A (en) 1980-10-20 1980-10-20 Pyrrolidines
US198,671 1981-10-20

Publications (1)

Publication Number Publication Date
KR830007550A true KR830007550A (ko) 1983-10-21

Family

ID=22734311

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004985A KR830007550A (ko) 1980-10-20 1981-12-18 시클릭아민의 제조방법

Country Status (12)

Country Link
US (1) US4342692A (ko)
EP (1) EP0050370B1 (ko)
JP (1) JPS57112370A (ko)
KR (1) KR830007550A (ko)
AT (1) ATE15187T1 (ko)
AU (1) AU552043B2 (ko)
CA (1) CA1206476A (ko)
DE (1) DE3172050D1 (ko)
DK (1) DK461881A (ko)
ES (1) ES507003A0 (ko)
IL (1) IL64107A0 (ko)
ZA (1) ZA817250B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK328382A (da) * 1981-07-22 1983-01-23 Syntex Inc Fremgangsmaade til fremstilling af antihypertensive midler
IE840151L (en) * 1983-01-24 1985-02-28 Syntex Inc £(3, 4-methylenedioxy-ó-hydroxybenzyl| pyrrolidine¹antihypertensives
US4548949A (en) * 1983-01-24 1985-10-22 Syntex (U.S.A.) Inc. +2-[(3,4-Methylenedioxy)phenethyl]-5-[(3-carboxamido-4-hydroxy)-α-hydroxybenzyl]pyrrolidines
AU2370084A (en) * 1983-01-24 1984-07-26 Syntex (U.S.A.) Inc. Pyrrolidine derivatives
US4701461A (en) * 1983-03-21 1987-10-20 Usv Pharmaceutical Corporation Substituted cyclic amines
US4569941A (en) * 1983-03-21 1986-02-11 Usv Pharmaceutical Corp. Method of using phenyl-alkylene-2-pyridyl derivatives to increase cardiac contractility in a mammal
US4548951A (en) * 1983-04-21 1985-10-22 Syntex (U.S.A.) Inc. Hypotensive benzoxathiole pyrrolidines
US4558066A (en) * 1984-05-17 1985-12-10 Syntex (U.S.A.) Inc. Treatment and prevention of ocular hypertension
US4632929A (en) * 1985-01-17 1986-12-30 Usv Pharmaceutical Corp. Method of hypertensive treatment using phenyl-alkylene-2-pyridyl derivatives
US4826869A (en) * 1988-02-19 1989-05-02 Syntex (U.S.A.) Inc. N-(lower alkyl)-2-(3'ureidobenzyl)pyrrolidines
EP0496884B1 (en) * 1989-10-17 1997-01-08 Nippon Soda Co., Ltd. Pyrrole monomer, process for preparing the same, and functional polymer film
US5093355A (en) * 1989-10-30 1992-03-03 Syntex (U.S.A.) Inc. Benzylpyrrolidine derivatives as dopamine agonists
JPH04294003A (ja) * 1991-03-22 1992-10-19 Inax Corp ユニットルームの模様付け方法
US6015824A (en) * 1998-02-10 2000-01-18 Hoffmann-La Roche Ag Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655693A (en) * 1969-06-25 1972-04-11 Merck & Co Inc Anti-inflammatory salicyclic acid derivatives
US3910934A (en) * 1970-05-21 1975-10-07 Minnesota Mining & Mfg Process for the preparation of {60 -(hydroxy and alkoxy substituted)phenyl-{60 -(2-piperidinyl)-methanols
US3941796A (en) * 1970-05-21 1976-03-02 Minnesota Mining And Manufacturing Company α-(Hydroxy and alkoxy substituted)phenyl-α-(2-piperidinyl)-methanols
ZA732136B (en) * 1972-04-12 1974-03-27 Lilly Co Eli Dopamine derivatives
FR2460929A1 (fr) * 1979-07-06 1981-01-30 Roussel Uclaf Nouveaux derives de l'a-phenyl 2-pyrrolidinemethanol et leur sels, procede de preparation, application a titre de medicaments et compositions les renfermant

Also Published As

Publication number Publication date
IL64107A0 (en) 1982-01-31
ZA817250B (en) 1982-09-29
JPH0250901B2 (ko) 1990-11-05
DE3172050D1 (en) 1985-10-03
JPS57112370A (en) 1982-07-13
ES8205769A1 (es) 1982-08-16
ES507003A0 (es) 1982-08-16
US4342692A (en) 1982-08-03
EP0050370A1 (en) 1982-04-28
DK461881A (da) 1982-04-21
AU552043B2 (en) 1986-05-22
AU7661781A (en) 1982-04-29
EP0050370B1 (en) 1985-08-28
CA1206476A (en) 1986-06-24
ATE15187T1 (de) 1985-09-15

Similar Documents

Publication Publication Date Title
KR830007550A (ko) 시클릭아민의 제조방법
GB1292768A (en) Substituted benzylimidazolidinones and a process for the manufacture thereof
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8406467A1 (es) "procedimiento para preparar nuevos benzo b tiofenos".
GB1313646A (en) Process for producing 3-phenyl pentenals
ES2138212T3 (es) Derivado de la vitamina d3 y procedimiento para producirlo.
DE69008851T2 (de) VERFAHREN ZUR HERSTELLUNG VON 5,6,7, -TRINOR- 4,8,-INTER-m-PHENYLEN PGI,2 Abkömmlingen.
KR960029336A (ko) 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
KR860001064A (ko) β-락탐 화합물의 제조방법
ES8703870A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
ES8502071A1 (es) Un procedimiento mejorado para producir etilenglicol
FI862557A0 (fi) Foerfarande foer framstaellning av en dibromnitrofoerening.
KR860002502A (ko) 1,3-옥사졸리딘-2-온 유도체의 제조방법
KR910007923A (ko) 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법
KR840006206A (ko) 이소퀴놀린 유도체의 제조방법
KR850006171A (ko) 피롤리디논 유도체의 제조방법
ES8306765A1 (es) "un procedimiento para preparar un derivado de antraciclina".
KR860001795A (ko) 트리아진 유도체의 제조방법
ES8102106A1 (es) Un procedimiento para preparar benzoxazepinas
ATE37393T1 (de) Mikroorganismusstamm chromobacterium violaceum, aus diesem hergestellte pharmazeutisch aktive verbindungen, ein verfahren zu deren herstellung und deren verwendung als medikamente.
ES466245A1 (es) Procedimiento para preparar derivados de isoquinolina
KR870004038A (ko) 제초제 화합물의 제조방법
KR830007592A (ko) 약리활성체 4-[2-히드록시-4-(치환)페닐]나프탈렌-2(1h)-온 및 2-올, 이들 유도체 및 이들 중간체의 제조방법
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법